您的位置: 首页 > 农业专利 > 详情页

ANABOLIC TARGETING STEM CELL GENE THERAPY FOR OSTEOPOROSIS
专利权人:
THE UNITE STATES OF AMERICA AS REPRESENTED BY UNTED STATES DEPARTMENT OF VETERANS AFFAIRS;FACULTY PHYSICIANS AND SURGEONS OF LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE;LOMA LINDA UNIVERSITY
发明人:
Zhang XIAOBING,Wanqui CHEN,David BAYLINK,Kin-Hing William LAU
申请号:
US17256509
公开号:
US20210177908A1
申请日:
2019.06.28
申请国别(地区):
US
年份:
2021
代理人:
摘要:
In one aspect, anabolic agent fusion proteins and compositions comprising anabolic agent fusion proteins are provided. In some embodiments, the anabolic agent fusion protein comprises a platelet derived growth factor (PDGF) or a fibroblast growth factor (FGF) and an Asp-Ser-Ser tripeptide (DSS) repeat sequence. In another aspect, methods of promoting bone growth and methods of treating a fracture using anabolic agent fusion proteins and compositions comprising anabolic agent fusion proteins are provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充